CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
NVSPhase 2

Asciminib Phase 2 Est. Readout

asciminib
Q2 2027~Q
CT.gov
00%
Dec '26
NVSPhase 2

Asciminib Phase 2 Est. Readout

asciminib
Dec 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Leukemia, Chronic Myelogenous

View Full Landscape
Drug Information

Target Indication

Leukemia, Chronic Myelogenous

Clinical Trial

NCT04795427

Last updated: 2/25/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.